Precision BioSciences
DTIL
70 hedge funds and large institutions have $62.9M invested in Precision BioSciences in 2025 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 7 reducing their positions, and 8 closing their positions.
1,210% more capital inflows, than outflows
Capital inflows: $64.4M | Capital outflows: $4.92M
200% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 7
175% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 8
25% more funds holding
Funds holding: 56 → 70 (+14)
21.68% more ownership
Funds ownership: 39.45% → 61.12% (+22%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Aberdeen Group
Edinburgh,
United Kingdom
|
+$12.1M |
| 2 |
Octagon Capital Advisors
New York
|
+$10.9M |
| 3 |
Boothbay Fund Management
New York
|
+$5.04M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$4.53M |
| 5 |
Driehaus Capital Management
Chicago,
Illinois
|
+$4.47M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tang Capital Management
San Diego,
California
|
-$3.61M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$358K |
| 3 |
Tejara Capital
London,
United Kingdom
|
-$324K |
| 4 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$276K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$113K |
DTIL Hedge Fund Activity: Q4 2025 in Review
70 of the 8,302 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2025, worth a combined $62.9M — up 145% from $25.7M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new DTIL positions and 8 closed out — a net gain of 14 holders — while 21 added to existing stakes and 7 trimmed.
The largest buyer was Aberdeen Group, opening a new position worth an estimated $12.1M. The largest seller was Tang Capital Management, exiting entirely with an estimated $3.61M sold.
- 70 institutional investors held Precision BioSciences (DTIL) as of Q4 2025, up from 56 in Q3 2025.
- Funds reported $62.9M of Precision BioSciences stock for Q4 2025, up 145% quarter-over-quarter.
- 22 funds opened new Precision BioSciences positions in Q4 2025 and 8 closed out, a net change of +14 holders.
- The largest Precision BioSciences buyer in Q4 2025 was Aberdeen Group, an estimated $12.1M added.
- The largest Precision BioSciences seller in Q4 2025 was Tang Capital Management, an estimated $3.61M sold.
Based on aggregated 13F filings for Q4 2025.